2025
September
19 September: EVCNA Journal and JSEV Announce New Partnership.
June
6 June: EVCNA achieved its first Impact Factor of 4.8 in the 2024 Journal Citation Reports, ranking Q1 in Biochemistry & Molecular Biology (75/319), Q2 in Cell Biology (65/204).
4 June: EVCNA journal's CiteScore increased significantly from 4.1 to 5.9, further consolidating its influence in the field.
January
4 January: the Article Processing Charge (APC) was officially adjusted to $2600.
2024
December
23 December: EVCNA was officially indexed in PubMed Central (PMC), enhancing the visibility and accessibility of its publications worldwide.
12 December: EVCNA Journal and GISM Announce New Partnership.
November
23 November: The first in-person Editorial Board Meeting in the Greater China Region was successfully held during the 2024 China (Guangxi)--ASEAN International Cancer Precision Medicine Conference.
October
9 October: EVCNA Journal and CzeSEV Announce New Partnership.
8 October: EVCNA Journal and GSEV Announce New Partnership.
July
9 July: EVCNA Journal and CzeSEV Announce New Partnership.
May
30 May: EVCNA was accepted for inclusion in the Emerging Sources Citation Index (ESCI), marking another important step in its academic recognition.
2023
May
4 May: EVCNA was accepted for coverage in Scopus, expanding its global reach.
April
20 April: EVCNA was indexed in the Chemical Abstracts Service (CAS) databases.
2022
December
29 December: The Second Editorial Board Meeting of EVCNA was successfully held.
February
25 February: EVCNA became a member of the Committee on Publication Ethics (COPE), affirming its commitment to the highest publishing standards.
2021
EVCNA was indexed in the CNKI database, broadening its readership in China.
2020
December
25 December: The inaugural issue of Extracellular Vesicles and Circulating Nucleic Acids (EVCNA) was officially released online.
Extracellular Vesicles and Circulating Nucleic Acids was officially launched with Dr. Yoke Peng Loh (NIH) serving as the Founding Editor-in-Chief.
